International Survey of Acute Coronary Syndromes
Launched by UNIVERSITY OF BOLOGNA · Oct 8, 2010
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The International Survey of Acute Coronary Syndromes in Transitional Countries (ISACS-TC) is a study aimed at understanding and improving treatment for patients experiencing serious heart conditions like unstable angina (chest pain) and heart attacks. Researchers want to gather information about patients with these conditions to ensure that they receive the best care possible according to international guidelines. The study is recruiting participants, including individuals aged 65 and older, regardless of gender, who have been diagnosed with acute coronary syndromes.
If you or a loved one has experienced a heart-related issue, you may be eligible to participate in this study. Participants will be asked to share their medical information, which will help healthcare providers learn more about these conditions and improve treatments. It's important to note that individuals who are younger or unable to give consent cannot join the study. By participating, you can contribute to advancing heart disease care in your community and beyond.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • acute coronary syndromes
- Exclusion Criteria:
- • under age or not able to give informed consent
About University Of Bologna
The University of Bologna, one of the oldest and most prestigious academic institutions in the world, is dedicated to advancing knowledge and innovation in the field of healthcare through rigorous clinical research. With a strong emphasis on interdisciplinary collaboration and cutting-edge methodologies, the university sponsors a diverse range of clinical trials aimed at enhancing patient outcomes and contributing to the scientific community. Its commitment to ethical standards and regulatory compliance ensures that all trials are conducted with the utmost integrity, fostering an environment of trust and excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, Emilia Romagna, Italy
Patients applied
Trial Officials
Raffaele Bugiardini, MD
Principal Investigator
University of Bologna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials